Improving vaccine stability for better global access
Enhancing Vaccine Thermostability with Natural Deep Eutectic Solvents
['FUNDING_R15'] · COLLEGE AT OSWEGO · NIH-10792289
This study is working on new ways to keep vaccines stable so they can be stored at room temperature, making it easier to get them to people in areas that don’t have refrigeration, especially for vaccines like those for yellow fever and adenoviruses.
Quick facts
| Phase | ['FUNDING_R15'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | COLLEGE AT OSWEGO (nih funded) |
| Locations | 1 site (OSWEGO, UNITED STATES) |
| Trial ID | NIH-10792289 on ClinicalTrials.gov |
What this research studies
This research focuses on enhancing the stability of vaccines by developing new natural deep eutectic solvents that can allow vaccines to be stored at ambient temperatures without refrigeration. By addressing the challenges posed by the cold chain system, the project aims to reduce vaccine wastage and improve access to vaccines in underserved areas. The approach involves creating formulations that can be tailored to stabilize specific vaccine types, such as those for yellow fever and adenoviruses, thereby facilitating their distribution and use in various environments.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals in regions with limited access to refrigeration or those affected by vaccine shortages.
Not a fit: Patients who already have reliable access to vaccines and refrigeration may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could significantly increase global access to vaccines by reducing the need for refrigeration and minimizing wastage.
How similar studies have performed: Other research has shown promise in using innovative materials to enhance vaccine stability, suggesting that this approach could lead to meaningful advancements.
Where this research is happening
OSWEGO, UNITED STATES
- COLLEGE AT OSWEGO — OSWEGO, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: MIRJAFARI, ARSALAN — COLLEGE AT OSWEGO
- Study coordinator: MIRJAFARI, ARSALAN
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.